These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2764536)

  • 1. Ceftriaxone disposition in open-heart surgery patients.
    Jungbluth GL; Pasko MT; Beam TR; Jusko WJ
    Antimicrob Agents Chemother; 1989 Jun; 33(6):850-6. PubMed ID: 2764536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients.
    Simon N; Dussol B; Sampol E; Purgus R; Brunet P; Lacarelle B; Berland Y; Bruguerolle B; Urien S
    Clin Pharmacokinet; 2006; 45(5):493-501. PubMed ID: 16640454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
    Joynt GM; Lipman J; Gomersall CD; Young RJ; Wong EL; Gin T
    J Antimicrob Chemother; 2001 Apr; 47(4):421-9. PubMed ID: 11266414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.
    Schleibinger M; Steinbach CL; Töpper C; Kratzer A; Liebchen U; Kees F; Salzberger B; Kees MG
    Br J Clin Pharmacol; 2015 Sep; 80(3):525-33. PubMed ID: 25808018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal protection in patients undergoing cardiopulmonary bypass with preoperative abnormal renal function.
    Lema G; Urzua J; Jalil R; Canessa R; Moran S; Sacco C; Medel J; Irarrazaval M; Zalaquett R; Fajardo C; Meneses G
    Anesth Analg; 1998 Jan; 86(1):3-8. PubMed ID: 9428842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting ceftriaxone plasma protein binding during open heart surgery.
    Jungbluth GL; Pasko MT; Jusko WJ
    J Pharm Sci; 1989 Oct; 78(10):807-11. PubMed ID: 2600784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cardiopulmonary bypass and deep hypothermic circulatory arrest on the thyroid axis during and after repair of congenital heart defects: preservation by deep hypothermia?
    Ririe DG; Butterworth JF; Hines M; Hammon JW; Zaloga GP
    Anesth Analg; 1998 Sep; 87(3):543-8. PubMed ID: 9728824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of ceftriaxone in critical care patients with acute renal failure.
    Heinemeyer G; Link J; Weber W; Meschede V; Roots I
    Intensive Care Med; 1990; 16(7):448-53. PubMed ID: 2269714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ceftriaxone in liver-transplant recipients.
    Toth A; Abdallah HY; Venkataramanan R; Teperman L; Halsf G; Rabinovitch M; Burckart GJ; Starzl TE
    J Clin Pharmacol; 1991 Aug; 31(8):722-8. PubMed ID: 1880231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary bypass time as a risk factor for acute renal failure.
    Taniguchi FP; Souza AR; Martins AS
    Rev Bras Cir Cardiovasc; 2007; 22(2):201-5. PubMed ID: 17992325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of extracorporeal circulation on renal function in coronary surgical patients.
    Lema G; Meneses G; Urzua J; Jalil R; Canessa R; Moran S; Irarrazaval MJ; Zalaquett R; Orellana P
    Anesth Analg; 1995 Sep; 81(3):446-51. PubMed ID: 7653802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered d-tubocurarine disposition during cardiopulmonary bypass surgery.
    Walker JS; Shanks CA; Brown KF
    Clin Pharmacol Ther; 1984 May; 35(5):686-94. PubMed ID: 6713781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone pharmacokinetics during iatrogenic hydroxyethyl starch-induced hypoalbuminemia: a model to explore the effects of decreased protein binding capacity on highly bound drugs.
    Mimoz O; Soreda S; Padoin C; Tod M; Petitjean O; Benhamou D
    Anesthesiology; 2000 Sep; 93(3):735-43. PubMed ID: 10969307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function and cardiopulmonary bypass in pediatric cardiac surgical patients.
    Lema G; Vogel A; Canessa R; Jalil R; Carvajal C; Becker P; Jaque MP; Fajardo C; Urzua J
    Pediatr Nephrol; 2006 Oct; 21(10):1446-51. PubMed ID: 16902783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary bypass-induced changes in plasma concentrations of propofol and in auditory evoked potentials.
    Hammarén E; Yli-Hankala A; Rosenberg PH; Hynynen M
    Br J Anaesth; 1996 Sep; 77(3):360-4. PubMed ID: 8949811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cardiopulmonary bypass management on postcardiac surgery renal function.
    Fischer UM; Weissenberger WK; Warters RD; Geissler HJ; Allen SJ; Mehlhorn U
    Perfusion; 2002 Nov; 17(6):401-6. PubMed ID: 12470028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass.
    Loef BG; Henning RH; Epema AH; Rietman GW; van Oeveren W; Navis GJ; Ebels T
    Br J Anaesth; 2004 Dec; 93(6):793-8. PubMed ID: 15377582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function and cardiopulmonary bypass: effect of perfusion pressure.
    Urzua J; Troncoso S; Bugedo G; Canessa R; Muñoz H; Lema G; Valdivieso A; Irarrazaval M; Moran S; Meneses G
    J Cardiothorac Vasc Anesth; 1992 Jun; 6(3):299-303. PubMed ID: 1610995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of probenecid on the elimination and protein binding of ceftriaxone.
    Stoeckel K; Trueb V; Dubach UC; McNamara PJ
    Eur J Clin Pharmacol; 1988; 34(2):151-6. PubMed ID: 3383987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery.
    Suen WS; Mok CK; Chiu SW; Cheung KL; Lee WT; Cheung D; Das SR; He GW
    Angiology; 1998 Oct; 49(10):789-800. PubMed ID: 9783643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.